Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
Clinical trial NCT07056777 · RECRUITING
Trial details
- NCT number
- NCT07056777
- Sponsor
- Zhejiang Doer Biologics Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-25
- Primary completion
- 2027-04-30
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.